BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2138067)

  • 1. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation.
    Gatenby PA; Barbosa JE; Lachmann PJ
    Clin Exp Immunol; 1990 Feb; 79(2):158-63. PubMed ID: 2138067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
    Reilly BD; Mold C
    Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.
    Holme ER; Veitch J; Johnston A; McKay IC; Whaley K
    Rheumatol Int; 1992; 12(5):187-90. PubMed ID: 1290020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35).
    Clemenza L; Isenman DE
    J Immunol; 2004 Feb; 172(3):1670-80. PubMed ID: 14734749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4.
    Gibb AL; Freeman AM; Smith RA; Edmonds S; Sim E
    Biochim Biophys Acta; 1993 Jan; 1180(3):313-20. PubMed ID: 8422437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of human C4A and C4B binding to an immune complex in serum.
    Reilly BD
    Clin Exp Immunol; 1999 Jul; 117(1):12-8. PubMed ID: 10403910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis.
    Lhotta K; Schlogl A; Kronenberg F; Joannidis M; Konig P
    Nephrol Dial Transplant; 1996 Jun; 11(6):1024-8. PubMed ID: 8671963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated adherence of immune complexes to human erythrocytes. Difference in the requirements for C4A and C4B.
    Schifferli JA; Hauptmann G; Paccaud JP
    FEBS Lett; 1987 Mar; 213(2):415-8. PubMed ID: 3493921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two isotypes of human C4, C4A and C4B have different structure and function.
    Schifferli JA; Paccaud JP
    Complement Inflamm; 1989; 6(1):19-26. PubMed ID: 2650988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
    Arason GJ; Kolka R; Hreidarsson AB; Gudjonsson H; Schneider PM; Fry L; Arnason A
    Clin Exp Immunol; 2005 Jun; 140(3):572-9. PubMed ID: 15932521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.
    Ittiprasert W; Kantachuvesiri S; Pavasuthipaisit K; Verasertniyom O; Chaomthum L; Totemchokchyakarn K; Kitiyanant Y
    J Autoimmun; 2005 Aug; 25(1):77-84. PubMed ID: 15998580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
    Lucisano Valim YM; Lachmann PJ
    Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway.
    Masaki T; Matsumoto M; Hara T; Nakanishi I; Kitamura H; Seya T
    Mol Immunol; 1995 Jan; 32(1):21-6. PubMed ID: 7870055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc ions inhibit factor I-mediated release of CR1-bound immune complexes and degradation of cell-bound complement factors C3b and C4b.
    Jepsen HH; Teisner B; Svehag SE
    Scand J Immunol; 1990 Apr; 31(4):397-403. PubMed ID: 2139734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.
    Sepp A; Dodds AW; Anderson MJ; Campbell RD; Willis AC; Law SK
    Protein Sci; 1993 May; 2(5):706-16. PubMed ID: 8495193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
    Fielder AH; Walport MJ; Batchelor JR; Rynes RI; Black CM; Dodi IA; Hughes GR
    Br Med J (Clin Res Ed); 1983 Feb; 286(6363):425-8. PubMed ID: 6401549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two hybrid C4 allotypes (C4A*12 and C4B*3) by electrophoretic, serological and restriction fragment length polymorphism analyses.
    McLean RH; Bias WB; Giles C; Yu CY; Campbell RD
    Tissue Antigens; 1990 Feb; 35(2):75-81. PubMed ID: 1693017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isotyping of human C4 complement using differences in the functional activity of C4A and C4B isotypes].
    Kozlov LV; Lakhtin VM; Skorokhodova TG; Batalova TN; Shoĭbonov BB; D'iakov VL; Guzova VA; Matveevskaia NS
    Bioorg Khim; 2000 Jul; 26(7):539-47. PubMed ID: 11008645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural differences between the two human complement C4 isotypes affect the humoral immune response.
    Finco O; Li S; Cuccia M; Rosen FS; Carroll MC
    J Exp Med; 1992 Feb; 175(2):537-43. PubMed ID: 1732415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C4A Regulates Autoreactive B Cells in Murine Lupus.
    Simoni L; Presumey J; van der Poel CE; Castrillon C; Chang SE; Utz PJ; Carroll MC
    Cell Rep; 2020 Nov; 33(5):108330. PubMed ID: 33147456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.